EBIT: Income before interest and taxes.
Cardiol Therapeutics Inc. (CRDL) had EBIT of $-7.39M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-7.23M |
|
-- |
|
-- |
|
$7.39M |
|
$-7.39M |
|
$0.16M |
|
$-7.23M |
|
$-7.23M |
|
$-7.23M |
|
$-7.23M |
|
$-7.23M |
|
$-7.23M |
|
|
EBIT |
$-7.39M |
$-7.37M |
|
84.73M |
|
84.73M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$9.30M |
|
$0.10M |
|
$0.10M |
|
$9.40M |
|
$2.39M |
|
$0.07M |
|
$0.07M |
|
$2.46M |
|
$6.94M |
|
$6.94M |
|
$6.94M |
|
87.46M |
|
| Cash Flow Statement Financials | |
$-13.52M |
|
$-0.02M |
|
$-0.01M |
|
$22.20M |
|
$8.44M |
|
$-13.76M |
|
$5.58M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.89 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-13.54M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-104.22% |
|
-104.22% |
|
-76.96% |
|
-103.17% |
|
$0.08 |
|
$-0.16 |
|
$-0.16 |
|